AMCP webinar that reviewed proceedings from this Partnership Forum.
Sponsored webinar that discussed topics such as, the RNAi overview, the disease burden of PH1, PH2 and PH3, and an RNAi technology as a potential treatment approach for this rare condition.
Partnership Forum: This forum identified key actions that can support access to and the appropriate management of treatments for rare diseases within the U.S. health care system.
Sponsored webinar that provided an overview of the ATTR amyloidosis disease subtypes, pathophysiology of disease, and the varying clinical presentations, including nonspecific symptoms that should raise suspicion of and aid in diagnosis of the disease.
More than 30 experts representing health plans, integrated delivery systems, health economists, providers, academicians, pharmaceutical manufacturers, and other professionals gathered for AMCP’s Partnership Forum to address the challenges in managing and providing timely access to rare and orphan disease therapies.
Sponsored webinar that educated payers on the important features of axial spondyloarthritis (axSpA) to help with early detection.
Disease management is the concept of reducing health care costs and improving quality of life for individuals with chronic conditions by preventing or minimizing the effects of the disease through integrated care. Disease management programs are designed to improve the health of persons with chronic conditions and reduce associated costs from avoidable complications by identifying and treating chronic conditions more quickly and more effectively, thus slowing the progression of those diseases.
Over the past several years, the introduction, utilization and cost share of specialty pharmacy products has been increasing at a rate substantially greater than that of other pharmaceuticals. This paper examines the characteristics of specialty pharmaceuticals; the growth of new expertise to handle and manage these pharmaceuticals; and the needs these products create for patients, health plans and practitioners.
The Academy of Managed Care Pharmacy (AMCP) thanks the Pharmacy Quality Alliance (PQA) for the opportunity to provide comments in response to the Call for Comments on PQA Endorsement Consideration of Two New Performance Measures.
Press Release: PRIME Education, Inc. (PRIME), the American Gastroenterological Association (AGA), and the Academy of Managed Care Pharmacy (AMCP), are pleased to announce a groundbreaking initiative in collegial learning between payers and providers to improve treatment decision-making in chronic and costly gastroenterological (GI) diseases.
